Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jul;31(7):735-737.
doi: 10.1038/s41431-023-01369-x. Epub 2023 May 15.

Investigation and management of pediatric moyamoya arteriopathy in the era of genotype-phenotype correlation studies

M L Kaseka  1 , N Dlamini  2
Affiliations
Comment

Investigation and management of pediatric moyamoya arteriopathy in the era of genotype-phenotype correlation studies

M L Kaseka et al. Eur J Hum Genet. 2023 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Approach to extracranial vascular involvement screening in moyamoya patients.
This diagram summarizes the authors’ suggested approach for screening extracranial and systemic vascular abnormalities in patients with moyamoya arteriopathy.
See this image and copyright information in PMC

Comment on

References

    1. Zanoni P, Steindl K, Sticht H, Oneda B, Joset P, Ivanovski I, et al. The genetic landscape and clinical implication of pediatric Moyamoya angiopathy in an international cohort. Eur J Hum Genet. 2023. 10.1038/s41431-023-01320-0. - PMC - PubMed
    1. Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011;56:34–40. doi: 10.1038/jhg.2010.132. - DOI - PubMed
    1. Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PloS One. 2011;6:e22542. doi: 10.1371/journal.pone.0022542. - DOI - PMC - PubMed
    1. Zhang Q, Liu Y, Zhang D, Wang R, Zhang Y, Wang S, et al. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance. J Neurosurg. 2017;126:1106–13. doi: 10.3171/2016.2.JNS152173. - DOI - PubMed
    1. Koizumi A, Kobayashi H, Hitomi T, Harada KH, Habu T, Youssefian S. A new horizon of moyamoya disease and associated health risks explored through RNF213. Environ Health Prev Med. 2016;21:55–70. doi: 10.1007/s12199-015-0498-7. - DOI - PMC - PubMed